Effectiveness and Quality of Life with Paliperidone Palmitate 3-Monthly in Comparison with Other Long-Acting Drugs

PURPOSE: Antipsychotic long-acting injections (AP-LAIs) are indicated for patients affected by schizophrenia especially those with poor treatment adherence. PATIENTS AND METHODS: To compare paliperidone palmitate 3-monthly (PP3M), paliperidone palmitate one-monthly (PP1M) and haloperidol decanoate (...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Lorenzo, Rosaria, Iorio, Anita, Pinelli, Margherita, Magarini, Federica, Marchi, Mattia, Sacchetti, Andrea, Calogero, Chiara, Galeazzi, Gian Maria, Ferri, Paola, Rovesti, Sergio, Minarini, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013412/
https://www.ncbi.nlm.nih.gov/pubmed/35440870
http://dx.doi.org/10.2147/NDT.S356341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013412/
https://www.ncbi.nlm.nih.gov/pubmed/35440870
http://dx.doi.org/10.2147/NDT.S356341

Ejemplares similares